Abstract 105P
Background
Cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-Seq) is a promising approach to assess non-invasive methylomics. Despite its cost-efficiency and accuracy, the setup and processing of cfMeDIP-Seq are technically challenging. The original protocol developed by Shen et al. in 2019 can now be partially automated, potentially improving reproducibility and yield.
Methods
We designed a pilot study to evaluate the performance of cfMeDIP-Seq under 4 library preparation conditions. We collected 4 K2EDTA and 4 PAXgene ccfDNA tubes (BD Vacutainer™) from the same healthy donor. We processed K2EDTA and PAXgene tubes within 2 and 6 hours of blood draw respectively, as previously described (Dameri et al., 2023). We used 10 ng of cfDNA for library preparation. Each condition underwent 2 parallel preparation procedures: one following the manual protocol described by Shen et al., and the other following a semi-automated version of the original protocol using the IP-Star® Compact instrument (Diagenode). We generated a total of 16 libraries, 4 for each condition, and sequenced them on Illumina NovaSeq 6000 device.
Results
The number of uniquely mapped reads was comparable (p-value = 0.8) between semi-automated and manually processed libraries, with an average of 19.9 MReads per sample. The percentage of duplicates was reduced (p-value = 0.0012) in semi-automated libraries (median = 32.88; IQR = 31.94-34.06) compared to manually prepared ones (median = 41.48; IQR = 35.61-42.53). Semi-automated libraries showed a longer mean insert size (255 bp) compared to manually processed libraries (243 bp) with a p-value < 0.01. Principal component analysis revealed no major differences between K2EDTA and PAXgene samples processed with the semi-automated protocol. We observed no significant differences across the 4 conditions in terms of GC content (47%, sd = 0.49).
Conclusions
In the present pilot study, we demonstrated that semi-automated library preparation outperformed the fully manual protocol, regardless of tube type but provided that K2EDTA were processed shortly after collection. Partial automation of fluidic handling seems extremely relevant to increase yield and quality of cfMeDIP-Seq experiments.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Associazione Italiana per la Ricerca sul Cancro (AIRC) and 5x1000 by Italian Ministry of Health.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
114P - Circulating microRNAs and response to oncological and surgical therapy in patients with locally advanced gastric cancer
Presenter: Vasileia Kokala-Dimitropoulou
Session: Cocktail & Poster Display session
Resources:
Abstract
115P - BrainStorm-NSE: Serum neuron-specific enolase as a biomarker for central nervous system metastases: A prospective cohort study
Presenter: Diogo Martins-Branco
Session: Cocktail & Poster Display session
Resources:
Abstract
116P - Switching to a multigenic parallel sequencing approach: The landscape of biomarkers profiling changing between immunohistochemistry and next generation sequencing advantages and sustainability from a public hospital in Northern Italy
Presenter: Giulia Ghirardi
Session: Cocktail & Poster Display session
Resources:
Abstract
117P - Homologous recombination deficiency (HRD) by shallow whole genome sequencing (sWGS): Seamless integration in an existing NGS somatic oncology workflow
Presenter: Etienne Muller
Session: Cocktail & Poster Display session
Resources:
Abstract
118P - Molecular diagnostics of gastrointestinal stromal tumors in the era of precision oncology
Presenter: Alena Kalfusova
Session: Cocktail & Poster Display session
Resources:
Abstract
119P - De novo and histologically transformed small-cell lung cancer is sensitive to lurbinectedin treatment through the modulation of EMT and NOTCH signaling pathways
Presenter: Triparna Sen
Session: Cocktail & Poster Display session
Resources:
Abstract
120P - Anti-angiogenic therapy or immunotherapy? A multicenter real-world study of patients with advanced non-small cell lung cancer with EGFR / HER2 exon 20 insertion mutations
Presenter: Tianqing Chu
Session: Cocktail & Poster Display session
Resources:
Abstract
121P - Clinical outcomes of compound EGFR mutation in non-small cell lung cancer: A national, retrospective, multicenter study
Presenter: Aurélien Brindel
Session: Cocktail & Poster Display session
Resources:
Abstract
122P - Molecular testing, treatment, and response of patients with advanced solid tumors harboring an NTRK gene fusion: Second interim results of the REALTRK registry
Presenter: Sebastian Lange
Session: Cocktail & Poster Display session
Resources:
Abstract
123P - Incidence and outcomes of anaplastic lymphoma kinase (ALK) and ROS 1 positive advanced NSCLC: A real world experience
Presenter: Stalin Chowdary Bala
Session: Cocktail & Poster Display session
Resources:
Abstract